Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family

被引:1
作者
Yang, Ciyu [1 ]
Sheehan, Margaret [2 ]
Borras, Ester [1 ]
Cadoo, Karen [2 ]
Offit, Kenneth [2 ]
Zhang, Liying [3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA
关键词
MLH1; Germline; c.678-3T > A; Lynch syndrome; Splice site variant; MESSENGER-RNA; MSH2; MUTATIONS;
D O I
10.1007/s10689-020-00180-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Germline mutations in the DNA mismatch repair (MMR) genes cause Lynch syndrome. Classification and interpretation of intronic variants, especially those outside the consensus +/- 1 similar to 2 splice sites are challenging as it is uncertain whether such variants would affect splicing accuracy and efficiency. The assessment of the pathogenicity of splice site variants in MLH1 is further complicated by the various isoforms due to alternative splicing. In this report, we describe a 42-year-old female with Lynch syndrome who carries a germline variant, MLH1 c.678-3T > A, in the splice acceptor site of intron 8. Functional studies and semiquantitative analysis demonstrated that this variant causes a significant increase in the transcripts with exon 9 or exon 9 and 10 deletions, which presumably leads to premature protein truncation or abnormal protein. In addition, we also observed MSI-H and loss of MLH1 by IHC in patient's tumor tissue. This variant also segregated with Lynch Syndrome related cancers in three affected family members. Based on these evidence, the MLH1 c.678-3T > A variant is considered pathogenic.
引用
收藏
页码:315 / 322
页数:8
相关论文
共 24 条
[1]   Classifying MLH1 and MSH2 Variants Using Bioinformatic Prediction, Splicing Assays, Segregation, and Tumor Characteristics [J].
Arnold, Sven ;
Buchanan, Daniel D. ;
Barker, Melissa ;
Jaskowski, Lesley ;
Walsh, Michael D. ;
Birney, Genevieve ;
Woods, Michael O. ;
Hopper, John L. ;
Jenkins, Mark A. ;
Brown, Melissa A. ;
Tavtigian, Sean V. ;
Goldgar, David E. ;
Young, Joanne P. ;
Spurdle, Amanda B. .
HUMAN MUTATION, 2009, 30 (05) :757-770
[2]   Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing [J].
Auclair, J ;
Buisine, MP ;
Navarro, C ;
Ruano, E ;
Montmain, G ;
Desseigne, F ;
Saurin, JC ;
Lasset, C ;
Bonadona, V ;
Giraud, S ;
Puisieux, A ;
Wang, Q .
HUMAN MUTATION, 2006, 27 (02) :145-154
[3]   An intronic mutation in MLH1 associated with familial colon and breast cancer [J].
Bianchi, F. ;
Raponi, M. ;
Piva, F. ;
Viel, A. ;
Bearzi, I. ;
Galizia, E. ;
Bracci, R. ;
Belvederesi, L. ;
Loretelli, C. ;
Brugiati, C. ;
Corradini, F. ;
Baralle, D. ;
Cellerino, R. .
FAMILIAL CANCER, 2011, 10 (01) :27-35
[4]   The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside [J].
Boland, C. Richard ;
Koi, Minoru ;
Chang, Dong K. ;
Carethers, John M. .
FAMILIAL CANCER, 2008, 7 (01) :41-52
[5]   Comprehensive functional assessment of MLH1 variants of unknown significance [J].
Borras, Ester ;
Pineda, Marta ;
Brieger, Angela ;
Hinrichsen, Inge ;
Gomez, Carolina ;
Navarro, Matilde ;
Balmana, Judit ;
Ramon y Cajal, Teresa ;
Torres, Asuncion ;
Brunet, Joan ;
Blanco, Ignacio ;
Plotz, Guido ;
Lazaro, Conxi ;
Capella, Gabriel .
HUMAN MUTATION, 2012, 33 (11) :1576-1588
[6]   Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer [J].
Casey, G ;
Lindor, NM ;
Papadopoulos, N ;
Thibodeau, SN ;
Moskow, J ;
Steelman, S ;
Buzin, CH ;
Sommer, SS ;
Collins, CE ;
Butz, M ;
Aronson, M ;
Gallinger, S ;
Barker, MA ;
Young, JP ;
Jass, JR ;
Hopper, JL ;
Diep, A ;
Bapat, B ;
Salem, M ;
Seminara, D ;
Haile, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (07) :799-809
[7]  
CHARBONNIER F, 1995, CANCER RES, V55, P1839
[8]   The genetic basis of Lynch syndrome and its implications for clinical practice and risk management [J].
Cohen, Stephanie A. ;
Leininger, Anna .
APPLICATION OF CLINICAL GENETICS, 2014, 7 :147-158
[9]   Update on Hereditary Colorectal Cancer [J].
Da Silva, Felipe Carneiro ;
Wernhoff, Patrik ;
Dominguez-Barrera, Constantino ;
Dominguez-Valentin, Mev .
ANTICANCER RESEARCH, 2016, 36 (09) :4399-4405
[10]   Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility [J].
Genuardi, M ;
Viel, A ;
Bonora, D ;
Capozzi, E ;
Bellacosa, A ;
Leonardi, F ;
Valle, R ;
Ventura, A ;
Pedroni, M ;
Boiocchi, M ;
Neri, G .
HUMAN GENETICS, 1998, 102 (01) :15-20